Freeline Therapeutics Holdings's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Freeline Therapeutics Holdings is scheduled to report earnings on May 15, 2023, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -18.02M	$ -22.93M	$ -26.56M	$ -27.79M	$ -31.40M
EBITDA	$ -17.70M	$ -22.52M	$ -26.08M	$ -27.24M	$ -30.79M
Net Income Common Stockholders	$ -23.00M	$ -14.89M	$ -24.35M	$ -26.73M	$ -34.70M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 47.28M	$ 65.85M	$ 90.00M	$ 113.10M	$ 117.66M
Total Assets	$ 86.64M	$ 100.08M	$ 162.13M	$ 196.17M	$ 141.13M
Total Debt	$ 5.92M	$ 11.96M	$ 57.41M	$ 59.63M	$ 0.00
Net Debt	$ -41.35M	$ -53.89M	$ -32.59M	$ -53.47M	$ -117.66M
Total Liabilities	$ 34.23M	$ 31.49M	$ 72.50M	$ 77.61M	$ 20.68M
Stockholders Equity	$ 52.41M	$ 68.58M	$ 89.63M	$ 118.56M	$ 120.44M
Cash Flow	-
Free Cash Flow	$ -23.75M	$ -17.35M	$ -17.03M	$ -27.11M	$ -17.93M
Operating Cash Flow	$ -19.85M	$ -15.17M	$ -16.62M	$ -26.58M	$ -17.29M
Investing Cash Flow	$ -3.90M	$ -2.18M	$ -413.00K	$ -526.00K	$ -636.00K
Financing Cash Flow	$ 88.00K	$ -3.00K	$ 2.19M	$ 25.25M	$ -1.09M

Currency in USD

Freeline Therapeutics Holdings Earnings and Revenue History

Income Statement >

Freeline Therapeutics Holdings Debt to Assets

Balance Sheet >

Freeline Therapeutics Holdings Cash Flow

Cash Flow >

Freeline Therapeutics Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing